Bessemer Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24
Closed 2655
2025
Q2
$0 Hold
24
﹤0.01% 2574
2025
Q1
$0 Sell
24
-56
-70% -$983 ﹤0.01% 2657
2024
Q4
$1K Hold
80
﹤0.01% 2377
2024
Q3
$1K Buy
+80
New +$1.28K ﹤0.01% 2490
2022
Q3
Sell
-139
Closed -$3K 2119
2022
Q2
$3K Hold
139
﹤0.01% 1685
2022
Q1
$5K Buy
+139
New +$4.47K ﹤0.01% 1536
2021
Q4
Sell
-140
Closed -$5K 1939
2021
Q3
$5K Buy
+140
New +$5.57K ﹤0.01% 1518
2020
Q3
Sell
-54,400
Closed -$1.74M 1574
2020
Q2
$1.74M Buy
54,400
+700
+1% +$23.2K 0.01% 529
2020
Q1
$1.5M Buy
53,700
+800
+2% +$30.9K 0.01% 501
2019
Q4
$2.44M Buy
52,900
+1,900
+4% +$89.3K 0.01% 502
2019
Q3
$2.7M Buy
51,000
+4,400
+9% +$227K 0.01% 437
2019
Q2
$2.46M Buy
46,600
+2,700
+6% +$144K 0.01% 473
2019
Q1
$2.48M Buy
43,900
+10,800
+33% +$606K 0.01% 404
2018
Q4
$1.74M Buy
33,100
+10,900
+49% +$620K 0.01% 428
2018
Q3
$1.28M Hold
22,200
﹤0.01% 518
2018
Q2
$1.26M Hold
22,200
﹤0.01% 519
2018
Q1
$1.3M Buy
22,200
+200
+0.9% +$11.2K 0.01% 515
2017
Q4
$1.2M Sell
22,000
-6,900
-24% -$358K ﹤0.01% 558
2017
Q3
$1.37M Hold
28,900
0.01% 566
2017
Q2
$1.34M Hold
28,900
0.01% 583
2017
Q1
$1.1M Hold
28,900
﹤0.01% 675
2016
Q4
$1.05M Buy
28,900
+10,700
+59% +$406K ﹤0.01% 694
2016
Q3
$778K Buy
+18,200
New +$812K ﹤0.01% 671

Other funds holding OFIX

Bessemer Group's OFIX Position: Q3 2025 in Review

Bessemer Group sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 24 shares.

Bessemer Group first reported a position in OFIX in Q3 2016 and held it in 23 quarters. The position peaked at $2.7M in Q3 2019. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Bessemer Group reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Bessemer Group sold 24 Orthofix Medical shares in Q3 2025.
  • Bessemer Group first reported a position in Orthofix Medical in Q3 2016 and held it in 23 quarters.
  • Bessemer Group's Orthofix Medical position peaked at $2.7M in Q3 2019.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Bessemer Group's 13F filing for Q3 2025, filed 5 Nov 2025.